logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

Shenzhen Senior Technology Material (06067) will distribute a dividend of RMB0.2 per 10 shares for the first three quarters.

date
19:04 03/11/2026
avatar
GMT Eight
Shenzhen Senior Technology Material (06067) announced that it will distribute a dividend of RMB0.2 per 10 shares for the first three quarters ended September 30, 2026.
Shenzhen Senior Technology Material (06067) announced that it will distribute an interim dividend of RMB0.2 per 10 shares for the first three quarters ended September 30, 2026.
Related Articles
US Stock Market Move | Eaton Corp. Plc (ETN.US) rose more than 7% as Q3 results beat expectations.
US Stock Market Move | Crypto-related stocks broadly rise; Hut 8 (HUT.US) gains over 14%.
US Stock Market Move | Q3 innovative drug revenue up 33% year-over-year; Teva Pharmaceutical Industries Limited Sponsored ADR (TEVA.US) rises over 4%.
US Stock Market Move | Eaton Corp. Plc (ETN.US) rose more than 7% as Q3 results beat expectations.
US Stock Market Move | Crypto-related stocks broadly rise; Hut 8 (HUT.US) gains over 14%.
US Stock Market Move | Q3 innovative drug revenue up 33% year-over-year; Teva Pharmaceutical Industries Limited Sponsored ADR (TEVA.US) rises over 4%.
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.